Lai Liyun, Ong Raymond, Li Juntao, Albani Salvatore
SingHealth Translational Immunology and Inflammation Centre, Singapore Health Services Pte Ltd, Singapore.
Cytometry A. 2015 Apr;87(4):369-74. doi: 10.1002/cyto.a.22640. Epub 2015 Feb 2.
CyTOF enables the study of the immune system with a complexity, depth, and multidimensionality never achieved before. However, the full potential of using CyTOF can be limited by scarce cell samples. Barcoding strategies developed based on direct labeling of cells using maleimido-monoamide-DOTA (m-DOTA) provide a very useful tool. However, using m-DOTA has some inherent problems, mainly associated with signal intensity. This may be a source of uncertainty when samples are multiplexed. As an alternative or complementary approach to m-DOTA, conjugating an antibody, specific for a membrane protein present on most immune cells, with different isotopes could address the issues of stability and signal intensity needed for effective barcoding. We chose for this purpose CD45, and designed experiments to address different types of cultures and the ability to detect extra- and intra-cellular targets. We show here that our approach provides an useful alternative to m-DOTA in terms of sensitivity, specificity, flexibility, and user-friendliness. Our manuscript provides details to effectively barcode immune cells, overcoming limitations in current technology and enabling the use of CyTOF with scarce samples (for instance precious clinical samples).
质谱流式细胞术(CyTOF)能够以前所未有的复杂性、深度和多维度性来研究免疫系统。然而,细胞样本稀缺可能会限制CyTOF的全部潜力。基于使用马来酰亚胺单酰胺 - DOTA(m - DOTA)直接标记细胞而开发的条形码策略提供了一种非常有用的工具。然而,使用m - DOTA存在一些固有问题,主要与信号强度有关。当样本进行多重分析时,这可能是不确定性的一个来源。作为m - DOTA的替代或补充方法,将针对大多数免疫细胞上存在的膜蛋白的抗体与不同同位素偶联,可以解决有效条形码所需的稳定性和信号强度问题。为此我们选择了CD45,并设计实验来研究不同类型的培养物以及检测细胞外和细胞内靶点的能力。我们在此表明,我们的方法在灵敏度、特异性、灵活性和用户友好性方面为m - DOTA提供了一种有用的替代方案。我们的论文提供了有效标记免疫细胞的详细信息,克服了当前技术的局限性,并使得能够在稀缺样本(例如珍贵的临床样本)中使用CyTOF。